Skip to main content
The Globe and Mail
Support Quality Journalism
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); }

Marijuana plants growing under lights at a medical-marijuana growing operation in Seattle.

Ted S. Warren/AP

Weed has come a long way since its hazy days as a soporific passed around at summer love-ins.

Today's pot dealers are dressed in suits, as heads of publicly traded companies that are following in the footsteps of Big Tobacco, critics say.

Big Marijuana "is already following the same successful business strategy by increasing potency and creating new delivery devices," warned a recent opinion piece in the New England Journal of Medicine.

Story continues below advertisement

But even as they devise new marketing strategies in anticipation of legal recreational use, marijuana producers are taking cues from Big Pharma, too.

Representatives of licensed medical marijuana companies have been making the rounds of Canadian doctors' offices to encourage physicians to consider prescribing pot, the Ottawa Citizen reported last week.

The tactic is cause for alarm in light of scanty evidence of marijuana's medical benefits, Dr. Louis Hugo Francescutti, the president of the Canadian Medical Association, is quoted as saying.

Licensed marijuana producers have "hired the best advertising firms," he said. "Now, they've got very professional, well-dressed men and women knocking on doctors' offices."

Nevertheless, Mary Jane hasn't quite shaken off her flower child past.

As of July, Canada's 13 licensed marijuana growers offer 220 types of cannabis on their websites, with far-out names such as Amnesia Haze, Durban Magic, God's Lemon Skunk and Warlock. Notable exceptions include CanniMed 22•1 and Mettrum Red No. 5, which sound quasi-pharmaceutical. As the Canadian Medical Association Journal pointed out, other licensed producers should drop the recreational names if they want the medical community to take them seriously.

They can't have it both ways - pot companies will have to decide whether they're peddling prescription medicine or fun bud.

Story continues below advertisement

Meanwhile, anyone up for a hit of medicinal Kali Mist?

Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies